Factors associated with premature mortality among young injection drug users in Vancouver
Open Access
- 1 January 2007
- journal article
- Published by Springer Nature in Harm Reduction Journal
- Vol. 4 (1) , 1
- https://doi.org/10.1186/1477-7517-4-1
Abstract
Young injection drug users (IDUs) may be at increased risk of premature mortality due to the health risks associated with injection drug use including overdoses and infections. However, there has been little research conducted on mortality causes, rates and associations among this population. We undertook this study to investigate patterns of premature mortality, prior to age 30 years, among young IDUs. Since 1996, 572 young (≤29 years) IDUs have been enrolled in the Vancouver Injection Drug Users Study (VIDUS). Semi-annually, participants have completed an interviewer-administered questionnaire and have undergone serologic testing for HIV and hepatitis C (HCV). Mortality data have been continually updated through linkages with the Provincial Coroner's Office. Crude and age-specific mortality rates, standardized mortality ratios, and life expectancy measures were calculated using person-time methods. Predictors of mortality were identified using Cox regression analyses. Twenty-two participants died prior to age 30 years during the follow-up period for an overall crude mortality rate of 1,368 per 100,000 person-years. Overall, young IDUs were 16.4 times (95% confidence interval [CI]; 9.1–27.1) more likely to die; young women IDUs were 54.1 times (95%CI; 29.6–90.8) and young men IDUs were 12.9 times (95%CI; 5.5, 25.3) more likely to die when compared to the Canadian non-IDU population of the same age. The leading observed cause of death among females was: homicide (N = 9); and among males: suicide (N = 3) and overdose (N = 3). In Cox regression analyses, factors associated with mortality were, HIV infection (Hazard Ratio [HR]: 4.55; CI: 1.92–10.80) and sex work (HR: 2.76; CI: 1.16–6.56). Premature mortality was 13 and 54 times higher among young men and women who use injection drugs in Vancouver than among the general population in Canada. The majority of deaths among the women were attributable to homicide, suggesting that interventions should occur not only through harm reduction services but also through structural interventions at the legal and policy level.Keywords
This publication has 23 references indexed in Scilit:
- Mortality among Participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV StudyClinical Infectious Diseases, 2007
- HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, RussiaAIDS, 2006
- Mortality in a Cohort of Street Youth in MontrealJAMA, 2004
- Mortality risk among new onset injection drug usersAddiction, 2004
- Changing Patterns in Causes of Death in a Cohort of Injecting Drug Users, 1980-2001Archives of internal medicine (1960), 2004
- Drug-related mortality and fatal overdose risk: Pilot cohort study of heroin users recruited from specialist drug treatment sites in LondonJournal of Urban Health, 2003
- Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug usersHepatology, 2002
- A prospective study of mortality among drug misusers during a 4‐year period after seeking treatmentAddiction, 2002
- Predictors of accidental fatal drug overdose among a cohort of injection drug usersAmerican Journal of Public Health, 2001
- Predictors of Mortality in the Amsterdam Cohort of Human Immunodeficiency Virus (HIV)-positive and HIV-negative Drug UsersAmerican Journal of Epidemiology, 1996